Proceeding contribution from Lord Wills (Labour) in the House of Commons on Tuesday, 13 June 2006. It occurred during Adjournment debate on Dementia.
Dementia
The hon. Gentleman is being extremely generous in giving way. Does he think that NICE has taken sufficient account of the needs of carers in making its evaluation? In other words, although a drug might have a relatively mild therapeutic impact in the early stages of dementia, its impact in giving respite to hard-pressed carers, who are often elderly themselves, is nevertheless considerable. Does he think that NICE has taken sufficient account of that?
Secondary information
- Type
- Proceeding contribution
- Reference
- 447 c234WH
- Session
- 2005-06
- Chamber / Committee
- Westminster Hall
- Subjects
- Carers Dementia Alzheimer's disease Diseases Drugs Medical treatments National Institute for Health and Care Excellence Research Testing Medical Research Council
- Link
- View this Proceeding contribution on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2025-03-28 13:02:54 +0000
- URI
- http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_329631
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_329631
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_329631